Registered Kenya · PPB

ILAPRAZ-10

ILAPRAZOLE

H2015/CTD2976/346 10 MG PER TABLET

What it does

Ilaprazole is a medication used to reduce stomach acid and treat related conditions.

Commonly used for: stomach ulcers, gastroesophageal reflux disease (GERD), excess stomach acid production

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Hard to find? We help patients in Kenya source rare medicines. We don't sell or dispense medicines - licensed pharmacies do.

Source this medicine

Registration & product details

Registration no.
H2015/CTD2976/346
Registration date
-
Expiry date
-
Status
Registered
Active ingredient
ILAPRAZOLE
Dosage form
10 MG PER TABLET
Strength
-
Pack size
-
Therapeutic class
-
Manufacturer / MAH
Galaxy Pharmaceutical
Applicant / LTR
-
Country of origin
FOREIGN
Manufacturer location
PRQC+GJ5, 3rd Parklands Ave, Nairobi, Kenya

Source: Pharmacy and Poisons Board · fetched 2026-01-28 20:50:25 · updated 2026-07-26 11:41:01

Disclaimer: This information is sourced from Pharmacy and Poisons Board (Kenya). Always consult a qualified healthcare professional before using any medication.

About this medicine

Ilaprazole is a medication used to reduce stomach acid and treat related conditions.

What it treats

  • stomach ulcers
  • gastroesophageal reflux disease (GERD)
  • excess stomach acid production

How it works

Ilaprazole works by blocking the production of stomach acid, helping to heal ulcers and reduce heartburn.

Who it's for

This medication is for adults and may be used for patients with acid-related stomach issues.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: ilaprazole

BNF-referenced

Ilaprazole is a proton pump inhibitor (PPI) used primarily for the treatment of acid-related gastrointestinal disorders. It acts by inhibiting the H+/K+ ATPase enzyme system at the surface of the gastric parietal cells, leading to a decrease in gastric acid secretion. This results in increased gastric pH and provides symptomatic relief in conditions associated with excessive gastric acid production.

Indications

  • Gastroesophageal reflux disease (GERD)
  • Peptic ulcer disease
  • Erosive esophagitis
  • Zollinger-Ellison syndrome
  • Helicobacter pylori eradication regimen

Dosage

Children: Refer to the BNF for Children for paediatric dosing information.

Adults: Refer to the BNF for specific adult dosing guidelines.

Mechanism of action

Ilaprazole selectively inhibits the H+/K+ ATPase enzyme in the gastric parietal cells, which is responsible for acid secretion. By blocking this enzyme, ilaprazole reduces the secretion of gastric acid, thereby increasing gastric pH.

Pharmacodynamics

The pharmacodynamic effects of ilaprazole manifest through its ability to suppress basal and stimulated gastric acid secretion, leading to a decrease in gastric acidity. This effect is dose-dependent and typically begins within hours of administration, with maximal suppression of acid secretion occurring after several days of consistent dosing.

Pharmacokinetics

Ilaprazole is rapidly absorbed, with peak plasma concentrations occurring within 1 to 2 hours after oral administration. It has a bioavailability of approximately 50%. The drug undergoes extensive hepatic metabolism, primarily via cytochrome P450 enzymes. The elimination half-life is about 1 to 2 hours, and the drug is primarily excreted in the urine. Dose adjustments may be necessary in patients with hepatic impairment.

Pregnancy

Ilaprazole should only be used in pregnancy if the potential benefit justifies the potential risk to the fetus. There are limited data on the safety of ilaprazole in pregnancy.

Breast-feeding

It is not known whether ilaprazole is excreted in human breast milk. Caution should be exercised when prescribing to breastfeeding women.

Storage

Store at room temperature, away from moisture and heat. Keep out of reach of children.

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

Molecular reference: ilaprazole

PubChem CID 214351

Molecular formula: C19H18N4O2S

Source: PubChem (NCBI) · pathways from PathBank, Reactome, WikiPathways & PharmGKB.